Europe Newcastle Disease Vaccine Market by Manufacturers, Countries, Type and Application, Forecast to 2022
'Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans.
Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines suitable for use in commercial chickens.
Scope of the Report:
This report focuses on the Newcastle Disease Vaccine in Europe market, especially in Germany, UK, France, Russia, and Italy. This report categorizes the market based on manufacturers, countries, type and application.
Market Segment by Manufacturers, this report covers
Chapter 1, to describe Newcastle Disease Vaccine Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;
Chapter 2, to analyze the manufacturers of Newcastle Disease Vaccine, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers in Europe, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the Europe market by countries, covering Germany, UK, France, Italy and Russia, with sales, price, revenue and market share of Newcastle Disease Vaccine, for each country, from 2012 to 2017;
Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type and application, from 2012 to 2017;
Chapter 7, 8, 9, 10 and 11, to analyze the key countries by manufacturers, Type and Application, covering Germany, UK, France, Italy and Russia, with sales, revenue and market share by manufacturers, types and applications;
Chapter 12, Newcastle Disease Vaccine market forecast, by countries, type and application, with sales, price, revenue and growth rate forecast, from 2017 to 2022;
Chapter 13, to analyze the manufacturing cost, key raw materials and manufacturing process etc.
Chapter 14, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);
Chapter 15, to describe Newcastle Disease Vaccine sales channel, distributors, traders, dealers etc.
Chapter 16 and 17, to describe Newcastle Disease Vaccine Research Findings and Conclusion, Appendix, methodology and data source
Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines suitable for use in commercial chickens.
Scope of the Report:
This report focuses on the Newcastle Disease Vaccine in Europe market, especially in Germany, UK, France, Russia, and Italy. This report categorizes the market based on manufacturers, countries, type and application.
Market Segment by Manufacturers, this report covers
- Merial
- CEVA
- QYH Biotech
- Ringpu Biology
- Yebio
- Harbin Veterinary Research Institute
- Merck Animal Health
- DHN
- Zoetis
- ChengDu Tecbond
- Elanco (Lohmann)
- FATRO
- CAVAC
- Vaksindo
- Germany
- UK
- France
- Russia
- Italy
- Live Vaccines
- Killed Vaccines
- Chicken
- Duck & Goose
- Other
Chapter 1, to describe Newcastle Disease Vaccine Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;
Chapter 2, to analyze the manufacturers of Newcastle Disease Vaccine, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers in Europe, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the Europe market by countries, covering Germany, UK, France, Italy and Russia, with sales, price, revenue and market share of Newcastle Disease Vaccine, for each country, from 2012 to 2017;
Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type and application, from 2012 to 2017;
Chapter 7, 8, 9, 10 and 11, to analyze the key countries by manufacturers, Type and Application, covering Germany, UK, France, Italy and Russia, with sales, revenue and market share by manufacturers, types and applications;
Chapter 12, Newcastle Disease Vaccine market forecast, by countries, type and application, with sales, price, revenue and growth rate forecast, from 2017 to 2022;
Chapter 13, to analyze the manufacturing cost, key raw materials and manufacturing process etc.
Chapter 14, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);
Chapter 15, to describe Newcastle Disease Vaccine sales channel, distributors, traders, dealers etc.
Chapter 16 and 17, to describe Newcastle Disease Vaccine Research Findings and Conclusion, Appendix, methodology and data source
1 MARKET OVERVIEW
1.1 Newcastle Disease Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Live Vaccines
1.2.2 Killed Vaccines
1.3 Market Analysis by Applications
1.3.1 Chicken
1.3.2 Duck & Goose
1.3.3 Other
1.4 Market Analysis by Countries
1.4.1 Germany Status and Prospect (2012-2022)
1.4.2 France Status and Prospect (2012-2022)
1.4.3 UK Status and Prospect (2012-2022)
1.4.4 Russia Status and Prospect (2012-2022)
1.4.5 Italy Status and Prospect (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 MANUFACTURERS PROFILES
2.1 Merial
2.1.1 Profile
2.1.2 Newcastle Disease Vaccine Type and Applications
2.1.2.1 Type
2.1.2.2 Type
2.1.3 Merial Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.4 Business Overview
2.1.5 Merial News
2.2 CEVA
2.2.1 Profile
2.2.2 Newcastle Disease Vaccine Type and Applications
2.2.2.1 Type
2.2.2.2 Type
2.2.3 CEVA Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.4 Business Overview
2.2.5 CEVA News
2.3 QYH Biotech
2.3.1 Profile
2.3.2 Newcastle Disease Vaccine Type and Applications
2.3.2.1 Type
2.3.2.2 Type
2.3.3 QYH Biotech Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.4 Business Overview
2.3.5 QYH Biotech News
2.4 Ringpu Biology
2.4.1 Profile
2.4.2 Newcastle Disease Vaccine Type and Applications
2.4.2.1 Type
2.4.2.2 Type
2.4.3 Ringpu Biology Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.4 Business Overview
2.4.5 Ringpu Biology News
2.5 Yebio
2.5.1 Profile
2.5.2 Newcastle Disease Vaccine Type and Applications
2.5.2.1 Type
2.5.2.2 Type
2.5.3 Yebio Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.4 Business Overview
2.5.5 Yebio News
2.6 Harbin Veterinary Research Institute
2.6.1 Profile
2.6.2 Newcastle Disease Vaccine Type and Applications
2.6.2.1 Type
2.6.2.2 Type
2.6.3 Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.4 Business Overview
2.6.5 Harbin Veterinary Research Institute News
2.7 Merck Animal Health
2.7.1 Profile
2.7.2 Newcastle Disease Vaccine Type and Applications
2.7.2.1 Type
2.7.2.2 Type
2.7.3 Merck Animal Health Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.4 Business Overview
2.7.5 Merck Animal Health News
2.8 DHN
2.8.1 Profile
2.8.2 Newcastle Disease Vaccine Type and Applications
2.8.2.1 Type
2.8.2.2 Type
2.8.3 DHN Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.4 Business Overview
2.8.5 DHN News
2.9 Zoetis
2.9.1 Profile
2.9.2 Newcastle Disease Vaccine Type and Applications
2.9.2.1 Type
2.9.2.2 Type
2.9.3 Zoetis Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.4 Business Overview
2.9.5 Zoetis News
2.10 ChengDu Tecbond
2.10.1 Profile
2.10.2 Newcastle Disease Vaccine Type and Applications
2.10.2.1 Type
2.10.2.2 Type
2.10.3 ChengDu Tecbond Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.4 Business Overview
2.10.5 ChengDu Tecbond News
2.11 Elanco (Lohmann)
2.11.1 Profile
2.11.2 Newcastle Disease Vaccine Type and Applications
2.11.2.1 Type
2.11.2.2 Type
2.11.3 Elanco (Lohmann) Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11.4 Business Overview
2.11.5 Elanco (Lohmann) News
2.12 FATRO
2.12.1 Profile
2.12.2 Newcastle Disease Vaccine Type and Applications
2.12.2.1 Type
2.12.2.2 Type
2.12.3 FATRO Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12.4 Business Overview
2.12.5 FATRO News
2.13 CAVAC
2.13.1 Profile
2.13.2 Newcastle Disease Vaccine Type and Applications
2.13.2.1 Type
2.13.2.2 Type
2.13.3 CAVAC Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13.4 Business Overview
2.13.5 CAVAC News
2.14 Vaksindo
2.14.1 Profile
2.14.2 Newcastle Disease Vaccine Type and Applications
2.14.2.1 Type
2.14.2.2 Type
2.14.3 Vaksindo Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14.4 Business Overview
2.14.5 Vaksindo News
3 EUROPE NEWCASTLE DISEASE VACCINE MARKET COMPETITION, BY MANUFACTURER
3.1 Europe Newcastle Disease Vaccine Sales and Market Share by Manufacturer (2016-2017)
3.2 Europe Newcastle Disease Vaccine Revenue and Market Share by Manufacturer (2016-2017)
3.3 Europe Newcastle Disease Vaccine Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Newcastle Disease Vaccine Manufacturer Market Share
3.4.2 Top 5 Newcastle Disease Vaccine Manufacturer Market Share
3.5 Market Competition Trend
4 EUROPE NEWCASTLE DISEASE VACCINE MARKET ANALYSIS BY COUNTRIES (2012-2017)
4.1 Europe Newcastle Disease Vaccine Sales Market Share by Countries (2012-2017)
4.2 Europe Newcastle Disease Vaccine Sales by Countries (2012-2017)
4.3 Europe Newcastle Disease Vaccine Revenue (Value) by Countries (2012-2017)
5 EUROPE MARKET SEGMENTATION NEWCASTLE DISEASE VACCINE BY TYPE
5.1 Europe Newcastle Disease Vaccine Sales, Revenue and Market Share by Type (2012-2017)
5.1.1 Europe Newcastle Disease Vaccine Sales and Market Share by Type (2012-2017)
5.1.2 Europe Newcastle Disease Vaccine Revenue and Market Share by Type (2012-2017)
5.2 Live Vaccines Sales Growth and Price
5.2.1 Europe Live Vaccines Sales Growth (2012-2017)
5.2.2 Europe Live Vaccines Price (2012-2017)
5.3 Killed Vaccines Sales Growth and Price
5.3.1 Europe Killed Vaccines Sales Growth (2012-2017)
5.3.2 Europe Killed Vaccines Price (2012-2017)
6 EUROPE MARKET SEGMENTATION NEWCASTLE DISEASE VACCINE BY APPLICATION
6.1 Europe Newcastle Disease Vaccine Sales Market Share by Application (2012-2017)
6.2 Chicken Sales Growth (2012-2017)
6.3 Duck & Goose Sales Growth (2012-2017)
6.4 Other Sales Growth (2012-2017)
7 GERMANY NEWCASTLE DISEASE VACCINE SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS
7.1 Germany Newcastle Disease Vaccine Revenue, Sales and Growth Rate (2012-2017)
7.2 Germany Newcastle Disease Vaccine Sales and Market Share by Type (2012-2017)
7.3 Germany Newcastle Disease Vaccine Sales by Application (2012-2017)
7.4 Germany Newcastle Disease Vaccine Sales, Revenue and Market Share by Manufacturer (2016-2017)
7.4.1 Germany Newcastle Disease Vaccine Sales and Market Share by Manufacturer (2016-2017)
7.4.2 Germany Newcastle Disease Vaccine Revenue and Market Share by Manufacturer
7.5 Germany Newcastle Disease Vaccine Export and Import (2012-2017)
8 UK NEWCASTLE DISEASE VACCINE SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS
8.1 UK Newcastle Disease Vaccine Revenue, Sales and Growth Rate (2012-2017)
8.2 UK Newcastle Disease Vaccine Sales and Market Share by Type (2012-2017)
8.3 UK Newcastle Disease Vaccine Sales by Application (2012-2017)
8.4 UK Newcastle Disease Vaccine Sales, Revenue and Market Share by Manufacturer (2016-2017)
8.4.1 UK Newcastle Disease Vaccine Sales and Market Share by Manufacturer
8.4.2 UK Newcastle Disease Vaccine Revenue and Market Share by Manufacturer
8.5 UK Newcastle Disease Vaccine Export and Import (2012-2017)
9 FRANCE NEWCASTLE DISEASE VACCINE SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS
9.1 France Newcastle Disease Vaccine Revenue, Sales and Growth Rate (2012-2017)
9.2 France Newcastle Disease Vaccine Sales and Market Share by Type (2012-2017)
9.3 France Newcastle Disease Vaccine Sales by Application (2012-2017)
9.4 France Newcastle Disease Vaccine Sales, Revenue and Market Share by Manufacturer (2016-2017)
9.4.1 France Newcastle Disease Vaccine Sales and Market Share by Manufacturer
9.4.2 France Newcastle Disease Vaccine Revenue and Market Share by Manufacturer
9.5 France Newcastle Disease Vaccine Export and Import (2012-2017)
10 RUSSIA NEWCASTLE DISEASE VACCINE SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS
10.1 Russia Newcastle Disease Vaccine Revenue, Sales and Growth Rate (2012-2017)
10.2 Russia Newcastle Disease Vaccine Sales and Market Share by Type
10.3 Russia Newcastle Disease Vaccine Sales by Application (2012-2017)
10.4 Russia Newcastle Disease Vaccine Sales, Revenue and Market Share by Manufacturer (2016-2017)
10.4.1 Russia Newcastle Disease Vaccine Sales and Market Share by Manufacturer
10.4.2 Russia Newcastle Disease Vaccine Revenue and Market Share by Manufacturer
10.5 Russia Newcastle Disease Vaccine Export and Import (2012-2017)
11 ITALY NEWCASTLE DISEASE VACCINE SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS
11.1 Italy Newcastle Disease Vaccine Revenue, Sales and Growth Rate (2012-2017)
11.2 Italy Newcastle Disease Vaccine Sales and Market Share by Type
11.3 Italy Newcastle Disease Vaccine Sales by Application (2012-2017)
11.4 Italy Newcastle Disease Vaccine Sales, Revenue and Market Share by Manufacturer (2016-2017)
11.4.1 Italy Newcastle Disease Vaccine Sales and Market Share by Manufacturer
11.4.2 Italy Newcastle Disease Vaccine Revenue and Market Share by Manufacturer
11.5 Italy Newcastle Disease Vaccine Export and Import (2012-2017)
12 NEWCASTLE DISEASE VACCINE MARKET FORECAST (2017-2022)
12.1 Europe Newcastle Disease Vaccine Sales, Revenue and Growth Rate (2017-2022)
12.2 Newcastle Disease Vaccine Market Forecast by Countries (2017-2022)
12.2.1 Germany Newcastle Disease Vaccine Sales Forecast (2017-2022)
12.2.2 UK Newcastle Disease Vaccine Sales Forecast (2017-2022)
12.2.3 France Newcastle Disease Vaccine Sales Forecast (2017-2022)
12.2.4 Russia Newcastle Disease Vaccine Sales Forecast (2017-2022)
12.2.5 Italy Newcastle Disease Vaccine Sales Forecast (2017-2022)
12.3 Newcastle Disease Vaccine Market Forecast by Type (2017-2022)
12.4 Newcastle Disease Vaccine Market Forecast by Application (2017-2022)
13 NEWCASTLE DISEASE VACCINE MANUFACTURING COST ANALYSIS
13.1 Newcastle Disease Vaccine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Price Trend of Key Raw Materials
13.1.3 Key Suppliers of Raw Materials
13.1.4 Market Concentration Rate of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.2.1 Raw Materials
13.2.2 Labor Cost
13.2.3 Manufacturing Expenses
13.3 Manufacturing Process Analysis of Newcastle Disease Vaccine
14 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
14.1 Newcastle Disease Vaccine Industrial Chain Analysis
14.2 Upstream Raw Materials Sourcing
14.3 Raw Materials Sources of Newcastle Disease Vaccine Major Manufacturers in 2015
14.4 Downstream Buyers
15 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
15.1 Sales Channel
15.1.1 Direct Marketing
15.1.2 Indirect Marketing
15.1.3 Marketing Channel Future Trend
15.2 Distributors, Traders and Dealers
16 RESEARCH FINDINGS AND CONCLUSION
17 APPENDIX
17.1 Methodology
17.2 Analyst Introduction
17.3 Data Source
1.1 Newcastle Disease Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Live Vaccines
1.2.2 Killed Vaccines
1.3 Market Analysis by Applications
1.3.1 Chicken
1.3.2 Duck & Goose
1.3.3 Other
1.4 Market Analysis by Countries
1.4.1 Germany Status and Prospect (2012-2022)
1.4.2 France Status and Prospect (2012-2022)
1.4.3 UK Status and Prospect (2012-2022)
1.4.4 Russia Status and Prospect (2012-2022)
1.4.5 Italy Status and Prospect (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 MANUFACTURERS PROFILES
2.1 Merial
2.1.1 Profile
2.1.2 Newcastle Disease Vaccine Type and Applications
2.1.2.1 Type
2.1.2.2 Type
2.1.3 Merial Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.4 Business Overview
2.1.5 Merial News
2.2 CEVA
2.2.1 Profile
2.2.2 Newcastle Disease Vaccine Type and Applications
2.2.2.1 Type
2.2.2.2 Type
2.2.3 CEVA Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.4 Business Overview
2.2.5 CEVA News
2.3 QYH Biotech
2.3.1 Profile
2.3.2 Newcastle Disease Vaccine Type and Applications
2.3.2.1 Type
2.3.2.2 Type
2.3.3 QYH Biotech Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.4 Business Overview
2.3.5 QYH Biotech News
2.4 Ringpu Biology
2.4.1 Profile
2.4.2 Newcastle Disease Vaccine Type and Applications
2.4.2.1 Type
2.4.2.2 Type
2.4.3 Ringpu Biology Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.4 Business Overview
2.4.5 Ringpu Biology News
2.5 Yebio
2.5.1 Profile
2.5.2 Newcastle Disease Vaccine Type and Applications
2.5.2.1 Type
2.5.2.2 Type
2.5.3 Yebio Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.4 Business Overview
2.5.5 Yebio News
2.6 Harbin Veterinary Research Institute
2.6.1 Profile
2.6.2 Newcastle Disease Vaccine Type and Applications
2.6.2.1 Type
2.6.2.2 Type
2.6.3 Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.4 Business Overview
2.6.5 Harbin Veterinary Research Institute News
2.7 Merck Animal Health
2.7.1 Profile
2.7.2 Newcastle Disease Vaccine Type and Applications
2.7.2.1 Type
2.7.2.2 Type
2.7.3 Merck Animal Health Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.4 Business Overview
2.7.5 Merck Animal Health News
2.8 DHN
2.8.1 Profile
2.8.2 Newcastle Disease Vaccine Type and Applications
2.8.2.1 Type
2.8.2.2 Type
2.8.3 DHN Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.4 Business Overview
2.8.5 DHN News
2.9 Zoetis
2.9.1 Profile
2.9.2 Newcastle Disease Vaccine Type and Applications
2.9.2.1 Type
2.9.2.2 Type
2.9.3 Zoetis Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.4 Business Overview
2.9.5 Zoetis News
2.10 ChengDu Tecbond
2.10.1 Profile
2.10.2 Newcastle Disease Vaccine Type and Applications
2.10.2.1 Type
2.10.2.2 Type
2.10.3 ChengDu Tecbond Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.4 Business Overview
2.10.5 ChengDu Tecbond News
2.11 Elanco (Lohmann)
2.11.1 Profile
2.11.2 Newcastle Disease Vaccine Type and Applications
2.11.2.1 Type
2.11.2.2 Type
2.11.3 Elanco (Lohmann) Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11.4 Business Overview
2.11.5 Elanco (Lohmann) News
2.12 FATRO
2.12.1 Profile
2.12.2 Newcastle Disease Vaccine Type and Applications
2.12.2.1 Type
2.12.2.2 Type
2.12.3 FATRO Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12.4 Business Overview
2.12.5 FATRO News
2.13 CAVAC
2.13.1 Profile
2.13.2 Newcastle Disease Vaccine Type and Applications
2.13.2.1 Type
2.13.2.2 Type
2.13.3 CAVAC Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13.4 Business Overview
2.13.5 CAVAC News
2.14 Vaksindo
2.14.1 Profile
2.14.2 Newcastle Disease Vaccine Type and Applications
2.14.2.1 Type
2.14.2.2 Type
2.14.3 Vaksindo Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14.4 Business Overview
2.14.5 Vaksindo News
3 EUROPE NEWCASTLE DISEASE VACCINE MARKET COMPETITION, BY MANUFACTURER
3.1 Europe Newcastle Disease Vaccine Sales and Market Share by Manufacturer (2016-2017)
3.2 Europe Newcastle Disease Vaccine Revenue and Market Share by Manufacturer (2016-2017)
3.3 Europe Newcastle Disease Vaccine Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Newcastle Disease Vaccine Manufacturer Market Share
3.4.2 Top 5 Newcastle Disease Vaccine Manufacturer Market Share
3.5 Market Competition Trend
4 EUROPE NEWCASTLE DISEASE VACCINE MARKET ANALYSIS BY COUNTRIES (2012-2017)
4.1 Europe Newcastle Disease Vaccine Sales Market Share by Countries (2012-2017)
4.2 Europe Newcastle Disease Vaccine Sales by Countries (2012-2017)
4.3 Europe Newcastle Disease Vaccine Revenue (Value) by Countries (2012-2017)
5 EUROPE MARKET SEGMENTATION NEWCASTLE DISEASE VACCINE BY TYPE
5.1 Europe Newcastle Disease Vaccine Sales, Revenue and Market Share by Type (2012-2017)
5.1.1 Europe Newcastle Disease Vaccine Sales and Market Share by Type (2012-2017)
5.1.2 Europe Newcastle Disease Vaccine Revenue and Market Share by Type (2012-2017)
5.2 Live Vaccines Sales Growth and Price
5.2.1 Europe Live Vaccines Sales Growth (2012-2017)
5.2.2 Europe Live Vaccines Price (2012-2017)
5.3 Killed Vaccines Sales Growth and Price
5.3.1 Europe Killed Vaccines Sales Growth (2012-2017)
5.3.2 Europe Killed Vaccines Price (2012-2017)
6 EUROPE MARKET SEGMENTATION NEWCASTLE DISEASE VACCINE BY APPLICATION
6.1 Europe Newcastle Disease Vaccine Sales Market Share by Application (2012-2017)
6.2 Chicken Sales Growth (2012-2017)
6.3 Duck & Goose Sales Growth (2012-2017)
6.4 Other Sales Growth (2012-2017)
7 GERMANY NEWCASTLE DISEASE VACCINE SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS
7.1 Germany Newcastle Disease Vaccine Revenue, Sales and Growth Rate (2012-2017)
7.2 Germany Newcastle Disease Vaccine Sales and Market Share by Type (2012-2017)
7.3 Germany Newcastle Disease Vaccine Sales by Application (2012-2017)
7.4 Germany Newcastle Disease Vaccine Sales, Revenue and Market Share by Manufacturer (2016-2017)
7.4.1 Germany Newcastle Disease Vaccine Sales and Market Share by Manufacturer (2016-2017)
7.4.2 Germany Newcastle Disease Vaccine Revenue and Market Share by Manufacturer
7.5 Germany Newcastle Disease Vaccine Export and Import (2012-2017)
8 UK NEWCASTLE DISEASE VACCINE SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS
8.1 UK Newcastle Disease Vaccine Revenue, Sales and Growth Rate (2012-2017)
8.2 UK Newcastle Disease Vaccine Sales and Market Share by Type (2012-2017)
8.3 UK Newcastle Disease Vaccine Sales by Application (2012-2017)
8.4 UK Newcastle Disease Vaccine Sales, Revenue and Market Share by Manufacturer (2016-2017)
8.4.1 UK Newcastle Disease Vaccine Sales and Market Share by Manufacturer
8.4.2 UK Newcastle Disease Vaccine Revenue and Market Share by Manufacturer
8.5 UK Newcastle Disease Vaccine Export and Import (2012-2017)
9 FRANCE NEWCASTLE DISEASE VACCINE SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS
9.1 France Newcastle Disease Vaccine Revenue, Sales and Growth Rate (2012-2017)
9.2 France Newcastle Disease Vaccine Sales and Market Share by Type (2012-2017)
9.3 France Newcastle Disease Vaccine Sales by Application (2012-2017)
9.4 France Newcastle Disease Vaccine Sales, Revenue and Market Share by Manufacturer (2016-2017)
9.4.1 France Newcastle Disease Vaccine Sales and Market Share by Manufacturer
9.4.2 France Newcastle Disease Vaccine Revenue and Market Share by Manufacturer
9.5 France Newcastle Disease Vaccine Export and Import (2012-2017)
10 RUSSIA NEWCASTLE DISEASE VACCINE SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS
10.1 Russia Newcastle Disease Vaccine Revenue, Sales and Growth Rate (2012-2017)
10.2 Russia Newcastle Disease Vaccine Sales and Market Share by Type
10.3 Russia Newcastle Disease Vaccine Sales by Application (2012-2017)
10.4 Russia Newcastle Disease Vaccine Sales, Revenue and Market Share by Manufacturer (2016-2017)
10.4.1 Russia Newcastle Disease Vaccine Sales and Market Share by Manufacturer
10.4.2 Russia Newcastle Disease Vaccine Revenue and Market Share by Manufacturer
10.5 Russia Newcastle Disease Vaccine Export and Import (2012-2017)
11 ITALY NEWCASTLE DISEASE VACCINE SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS
11.1 Italy Newcastle Disease Vaccine Revenue, Sales and Growth Rate (2012-2017)
11.2 Italy Newcastle Disease Vaccine Sales and Market Share by Type
11.3 Italy Newcastle Disease Vaccine Sales by Application (2012-2017)
11.4 Italy Newcastle Disease Vaccine Sales, Revenue and Market Share by Manufacturer (2016-2017)
11.4.1 Italy Newcastle Disease Vaccine Sales and Market Share by Manufacturer
11.4.2 Italy Newcastle Disease Vaccine Revenue and Market Share by Manufacturer
11.5 Italy Newcastle Disease Vaccine Export and Import (2012-2017)
12 NEWCASTLE DISEASE VACCINE MARKET FORECAST (2017-2022)
12.1 Europe Newcastle Disease Vaccine Sales, Revenue and Growth Rate (2017-2022)
12.2 Newcastle Disease Vaccine Market Forecast by Countries (2017-2022)
12.2.1 Germany Newcastle Disease Vaccine Sales Forecast (2017-2022)
12.2.2 UK Newcastle Disease Vaccine Sales Forecast (2017-2022)
12.2.3 France Newcastle Disease Vaccine Sales Forecast (2017-2022)
12.2.4 Russia Newcastle Disease Vaccine Sales Forecast (2017-2022)
12.2.5 Italy Newcastle Disease Vaccine Sales Forecast (2017-2022)
12.3 Newcastle Disease Vaccine Market Forecast by Type (2017-2022)
12.4 Newcastle Disease Vaccine Market Forecast by Application (2017-2022)
13 NEWCASTLE DISEASE VACCINE MANUFACTURING COST ANALYSIS
13.1 Newcastle Disease Vaccine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Price Trend of Key Raw Materials
13.1.3 Key Suppliers of Raw Materials
13.1.4 Market Concentration Rate of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.2.1 Raw Materials
13.2.2 Labor Cost
13.2.3 Manufacturing Expenses
13.3 Manufacturing Process Analysis of Newcastle Disease Vaccine
14 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
14.1 Newcastle Disease Vaccine Industrial Chain Analysis
14.2 Upstream Raw Materials Sourcing
14.3 Raw Materials Sources of Newcastle Disease Vaccine Major Manufacturers in 2015
14.4 Downstream Buyers
15 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
15.1 Sales Channel
15.1.1 Direct Marketing
15.1.2 Indirect Marketing
15.1.3 Marketing Channel Future Trend
15.2 Distributors, Traders and Dealers
16 RESEARCH FINDINGS AND CONCLUSION
17 APPENDIX
17.1 Methodology
17.2 Analyst Introduction
17.3 Data Source
LIST OF TABLES AND FIGURES
Figure Newcastle Disease Vaccine Picture
Table Product Specifications of Newcastle Disease Vaccine
Figure Europe Sales Market Share of Newcastle Disease Vaccine by Types in 2016
Table Types of Ne
Figure Newcastle Disease Vaccine Picture
Table Product Specifications of Newcastle Disease Vaccine
Figure Europe Sales Market Share of Newcastle Disease Vaccine by Types in 2016
Table Types of Ne
